Skip to main content

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

Feedback
Newsletter
RSS
Twitter

User Top Menu

Welcome, guest
Log In
Join
Why Join?

Search form

Search

About Us
- Overview
- Who We Are
- Contact
- Fan Mail
- How to Cite
News & Future Directions
Papers
Forums
- Discussions
- Webinars
Professional Resources
Research Resources
Click Here to Support MSDF

You are here

Most Viewed

Gray matter SWI-filtered phase and atrophy are linked to disability in MS .
How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosis.
Polymorphism in Leptin and Leptin Receptor Genes May Modify Leptin Levels and Represent Risk Factors for Multiple Sclerosis.
Effect of disease duration on personality type in multiple sclerosis patients and healthy individual.
Biologics-induced autoimmune diseases.
Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results.
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.
Estriol Treatment in Multiple Sclerosis: Effect on Cognition
Interferon-beta stabilizes barrier characteristics of the blood-brain barrier in four different species in vitro.
Autoimmune myelopathies.
Synergistic Effects of Reserve and Adaptive Personality in Multiple Sclerosis.
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
Copaxone
Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder.
Iran mass produces MS drug Ziferon
Clinical Reasoning: Left hemiparesis, ataxia, and optic neuritis in a child previously treated for pineoblastoma.
Oligodendroglial membrane dynamics in relation to myelin biogenesis.
Zebrafish: A new vertebrate model for visualizing myelination in vivo.
Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)
National MS Society: Ralph I. Straus Award
Product Portfolio, Meda
SoCal Symposium on Glial-Neuronal Interactions in Health & Disease
A randomized controlled phase II trial of riluzole in early multiple sclerosis.
Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis.
Chemotherapeutics in the treatment of multiple sclerosis.

Pages

« first
‹ previous
…
87
88
89
90
91
92
93
94
95
…
next ›
last »

MSDF Footer

Copyright © 2014 MGH and ACP

Privacy
Terms of Use
How to Cite
FAQ/Help
Site Map
Support Us
Feedback
Image Credits

All site content, except where otherwise noted, is licensed under a Creative Commons BY license. Please let us know where and how you use MSDF material.

Content By

Software By